Targeting CMTM6 to modulate cell surface PD-L1 expression and antitumour immune responses

被引：0
|
作者：
Burr, Marian L. [1 ,2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS7-4
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [31] Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
    Zhang, Chao
    Zhao, Shutao
    Wang, Xudong
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [32] Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer
    Chao Zhang
    Shutao Zhao
    Xudong Wang
    Cancer Cell International, 21
  • [33] Expression and Clinical Significance of CMTM6 and PD-L1 in Triple-Negative Breast Cancer
    Shi, Shuai
    Ma, Hong-Yan
    Sang, Yin-zhou
    Ju, Ying-Bo
    Liu, Xiao-Yun
    Zhang, Zhi-Gang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [34] Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
    Takeuchi, Hiroto
    Konnai, Satoru
    Maekawa, Naoya
    Minato, Erina
    Ichikawa, Yoshiki
    Kobayashi, Atsushi
    Okagawa, Tomohiro
    Murata, Shiro
    Ohashi, Kazuhiko
    FRONTIERS IN VETERINARY SCIENCE, 2020, 7
  • [35] CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer
    Peng, Qi-Hua
    Wang, Chun-Hua
    Chen, Hong-Min
    Zhang, Rong-Xin
    Pan, Zhi-Zhong
    Lu, Zhen-Hai
    Wang, Gao-Yuan
    Yue, Xin
    Huang, Wenlin
    Liu, Ran-Yi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [36] Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors
    Imamovic, Denira
    Vranic, Semir
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [37] Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
    Xiao, Malina
    Hasmim, Meriem
    Lequeux, Audrey
    Van Moer, Kris
    Tan, Tuan Zea
    Gilles, Christine
    Hollier, Brett G.
    Thiery, Jean Paul
    Berchem, Guy
    Janji, Bassam
    Noman, Muhammad Zaeem
    CANCERS, 2021, 13 (05) : 1 - 12
  • [38] Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
    Xue, Hui
    Qiu, Bin
    Wang, Hao
    Jiang, Ping
    Zhang, Weiwei
    Xue, Lixiang
    Wang, Junjie
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (08) : 1193 - 1196
  • [39] CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
    Miao, Beiping
    Hu, Zhaoqing
    Mezzadra, Riccardo
    Hoeijmakers, Lotte
    Fauster, Astrid
    Du, Shangce
    Yang, Zhi
    Sator-Schmitt, Melanie
    Engel, Helena
    Li, Xueshen
    Broderick, Caroline
    Jin, Guangzhi
    Gomez-Eerland, Raquel
    Rozeman, Lisette
    Lei, Xin
    Matsuo, Hitoshi
    Yang, Chen
    Hofland, Ingrid
    Peters, Dennis
    Broeks, Annegien
    Laport, Elke
    Fitz, Annika
    Zhao, Xiyue
    Mahmoud, Mohamed A. A.
    Ma, Xiujian
    Sander, Sandrine
    Liu, Hai-kun
    Cui, Guoliang
    Gan, Yu
    Wu, Wei
    Xiao, Yanling
    Heck, Albert J. R.
    Guan, Wenxian
    Lowe, Scott W.
    Horlings, Hugo M.
    Wang, Cun
    Brummelkamp, Thijn R.
    Blank, Christian U.
    Schumacher, Ton N. M.
    Sun, Chong
    CANCER CELL, 2023, 41 (10) : 1817 - +
  • [40] CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
    Li, Xin
    Chen, Ling
    Gu, Chuan
    Sun, Qiaoli
    Li, Jia
    PEERJ, 2020, 8
12345